![]() | KIMBALL ELECTRONICS REPORTS Q2 RESULTS; WITH STRONG SALES GROWTH IN THE MEDICAL VERTICAL; COMPANY RAISES ITS GUIDANCE FOR FISCAL 2026 | ||||
“I’m pleased with the results for the second quarter and our updated guidance for fiscal 2026. Sales in Q2 were in line with expectations, highlighted by another quarter of strong double-digit year-over-year growth in the medical vertical, margins improved compared to the same period last year, and cash from operations was positive for the eighth consecutive quarter. Our focus as a medical CMO continues to gain momentum as we leverage our unique capabilities in the industry. We expect top-line growth in medical to outpace our other two verticals as we balance our portfolio across the markets we serve. Our recent announcement to rebrand as Kimball Solutions, and the grand opening of the new medical manufacturing facility in Indianapolis, reflects this strategy and our expanded offering of capabilities and services.” Richard D. Phillips Chief Executive Officer | Second Quarter 2026 Highlights •Revenue of $341.3 million, a 5% decrease compared to Q2 of fiscal 2025 •Sales in the medical vertical increased 15% year-over-year •Operating income of $10.8 million, or 3.2% of net sales •Adjusted operating income of 4.5%, up 80 bps year-over-year •Cash from operations of $6.9 million, the eighth consecutive quarter of positive operating cash generation •Debt of $154.2 million and borrowing capacity of $285.1 million •Cash Conversion Days of 91, a 16-day improvement compared to the same period last year •Invested $4.3 million to repurchase 149,000 shares of common stock •Company increases guidance for fiscal 2026 sales and adjusted operating income | |||||||||||||||||||
Net Sales by Vertical Market For Q2 Fiscal 2026 | ||||||||
Sales in the medical vertical market increased 15% compared to the second quarter of fiscal 2025, while sales in automotive decreased 13% and industrial decreased 5%. | ||||||||
![]() | ||||||||
*Percentage of net sales. | ||||||||
| ** | Percentage changes compared to Q2 of fiscal 2025. | |||||||
| AT&M excluded from all amounts, percentages, and periods. | ||||||||
![]() | Conference Call / Webcast | ||||
Thursday, February 5, 2026 Live Webcast: investors.kimballelectronics.com/events-and-presentations/events For those unable to participate in the live webcast, the call will be archived at investors.kimballelectronics.com. | |||||
Forward-Looking Statements | ||
Non-GAAP Financial Measures | ||
| About Kimball Electronics, Inc. | ||
![]() | Contact: Andrew D. Regrut Vice President, Investor Relations, Strategic Development, and Treasurer 812.827.4151 Investor.Relations@kimballelectronics.com | |||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| December 31, | December 31, | ||||||||||||||||||||||
| (Amounts in Thousands, except EPS) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Net Sales | $ | 341,280 | $ | 357,392 | $ | 706,883 | $ | 731,648 | |||||||||||||||
Operating Income | $ | 10,767 | $ | 8,230 | $ | 25,221 | $ | 17,345 | |||||||||||||||
Adjusted Operating Income (non-GAAP) | $ | 15,308 | $ | 13,333 | $ | 32,842 | $ | 25,923 | |||||||||||||||
| Operating Income % | 3.2 | % | 2.3 | % | 3.6 | % | 2.4 | % | |||||||||||||||
| Adjusted Operating Income (non-GAAP) % | 4.5 | % | 3.7 | % | 4.6 | % | 3.5 | % | |||||||||||||||
| Net Income | $ | 3,637 | $ | 3,432 | $ | 13,723 | $ | 6,586 | |||||||||||||||
Adjusted Net Income (non-GAAP) | $ | 6,925 | $ | 7,354 | $ | 19,175 | $ | 12,881 | |||||||||||||||
Diluted EPS | $ | 0.15 | $ | 0.14 | $ | 0.55 | $ | 0.26 | |||||||||||||||
Adjusted Diluted EPS (non-GAAP) | $ | 0.28 | $ | 0.29 | $ | 0.77 | $ | 0.51 | |||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| December 31, | December 31, | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (Amounts in Millions) | 2025 | * | 2024 (2) | * | Percent Change | 2025 | * | 2024 (2) | * | Percent Change | |||||||||||||||||||||||||||||||||||||||||||||||||
Automotive | $ | 162.3 | 48 | % | $ | 186.3 | 52 | % | (13) | % | $ | 326.7 | 46 | % | $ | 368.0 | 50 | % | (11) | % | |||||||||||||||||||||||||||||||||||||||
Medical | 96.3 | 28 | % | 84.0 | 23 | % | 15 | % | 197.9 | 28 | % | 173.8 | 24 | % | 14 | % | |||||||||||||||||||||||||||||||||||||||||||
Industrial excluding AT&M (1) | 82.7 | 24 | % | 87.1 | 25 | % | (5) | % | 182.3 | 26 | % | 187.7 | 26 | % | (3) | % | |||||||||||||||||||||||||||||||||||||||||||
Net Sales excluding AT&M (1) | $ | 341.3 | 100 | % | $ | 357.4 | 100 | % | (5) | % | $ | 706.9 | 100 | % | $ | 729.5 | 100 | % | (3) | % | |||||||||||||||||||||||||||||||||||||||
AT&M (1) | — | — | % | — | — | % | — | % | — | — | % | 2.1 | — | % | (100) | % | |||||||||||||||||||||||||||||||||||||||||||
| Total Net Sales | $ | 341.3 | 100 | % | $ | 357.4 | 100 | % | (5) | % | $ | 706.9 | 100 | % | $ | 731.6 | 100 | % | (3) | % | |||||||||||||||||||||||||||||||||||||||
*As a percent of Total Net Sales | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(1)Sales from our Automation, Test, and Measurement business (AT&M), which was divested effective July 31, 2024, were previously included in the industrial vertical | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(2)Beginning in the first quarter of fiscal year 2026, sales to customers related to commercial transportation, previously included in the automotive vertical, are now reflected in the industrial vertical; prior periods have been recast to conform to current period presentation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
–Automotive includes electronic power steering, body controls, advanced driver-assistance systems, and electronic braking systems | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
–Industrial includes climate controls, automation controls, public safety, IoT and factory automation, efficient energy, off highway equipment, and commercial transportation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Consolidated Statements of Income | |||||||||||||||||||||||
| (Unaudited) | Three Months Ended | ||||||||||||||||||||||
| (Amounts in Thousands, except Per Share Data) | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||
| Net Sales | $ | 341,280 | 100.0 | % | $ | 357,392 | 100.0 | % | |||||||||||||||
| Cost of Sales | 313,412 | 91.8 | % | 333,965 | 93.4 | % | |||||||||||||||||
| Gross Profit | 27,868 | 8.2 | % | 23,427 | 6.6 | % | |||||||||||||||||
| Selling and Administrative Expenses | 14,862 | 4.4 | % | 10,526 | 3.0 | % | |||||||||||||||||
| Restructuring Expense | 1,817 | 0.5 | % | 4,671 | 1.3 | % | |||||||||||||||||
Asset Impairment | 422 | 0.1 | % | — | — | % | |||||||||||||||||
Operating Income | 10,767 | 3.2 | % | 8,230 | 2.3 | % | |||||||||||||||||
| Interest Income | 375 | 0.1 | % | 253 | 0.1 | % | |||||||||||||||||
| Interest Expense | (2,095) | (0.6) | % | (4,241) | (1.2) | % | |||||||||||||||||
| Non-Operating Income (Expense), net | (2,063) | (0.7) | % | (768) | (0.2) | % | |||||||||||||||||
| Other Income (Expense), net | (3,783) | (1.2) | % | (4,756) | (1.3) | % | |||||||||||||||||
| Income Before Taxes on Income | 6,984 | 2.0 | % | 3,474 | 1.0 | % | |||||||||||||||||
| Provision (Benefit) for Income Taxes | 3,347 | 0.9 | % | 42 | — | % | |||||||||||||||||
Net Income | $ | 3,637 | 1.1 | % | $ | 3,432 | 1.0 | % | |||||||||||||||
| Earnings Per Share of Common Stock: | |||||||||||||||||||||||
| Basic | $ | 0.15 | $ | 0.14 | |||||||||||||||||||
| Diluted | $ | 0.15 | $ | 0.14 | |||||||||||||||||||
| Average Number of Shares Outstanding: | |||||||||||||||||||||||
| Basic | 24,606 | 24,870 | |||||||||||||||||||||
| Diluted | 24,823 | 24,968 | |||||||||||||||||||||
| (Unaudited) | Six Months Ended | ||||||||||||||||||||||
| (Amounts in Thousands, except Per Share Data) | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||
| Net Sales | $ | 706,883 | 100.0 | % | $ | 731,648 | 100.0 | % | |||||||||||||||
| Cost of Sales | 650,179 | 92.0 | % | 684,621 | 93.6 | % | |||||||||||||||||
| Gross Profit | 56,704 | 8.0 | % | 47,027 | 6.4 | % | |||||||||||||||||
| Selling and Administrative Expenses | 27,952 | 3.9 | % | 23,953 | 3.2 | % | |||||||||||||||||
| Restructuring Expense | 3,233 | 0.5 | % | 6,993 | 1.0 | % | |||||||||||||||||
| Asset Impairment (Gain on Disposal) | 298 | — | % | (1,264) | (0.2) | % | |||||||||||||||||
| Operating Income | 25,221 | 3.6 | % | 17,345 | 2.4 | % | |||||||||||||||||
| Interest Income | 514 | 0.1 | % | 475 | 0.1 | % | |||||||||||||||||
| Interest Expense | (4,448) | (0.6) | % | (9,033) | (1.2) | % | |||||||||||||||||
| Non-Operating Income (Expense), net | (3,304) | (0.6) | % | (2,429) | (0.4) | % | |||||||||||||||||
| Other Income (Expense), net | (7,238) | (1.1) | % | (10,987) | (1.5) | % | |||||||||||||||||
| Income Before Taxes on Income | 17,983 | 2.5 | % | 6,358 | 0.9 | % | |||||||||||||||||
Provision (Benefit) for Income Taxes | 4,260 | 0.6 | % | (228) | — | % | |||||||||||||||||
| Net Income | $ | 13,723 | 1.9 | % | $ | 6,586 | 0.9 | % | |||||||||||||||
| Earnings Per Share of Common Stock: | |||||||||||||||||||||||
| Basic | $ | 0.56 | $ | 0.26 | |||||||||||||||||||
| Diluted | $ | 0.55 | $ | 0.26 | |||||||||||||||||||
| Average Number of Shares Outstanding: | |||||||||||||||||||||||
| Basic | 24,603 | 24,924 | |||||||||||||||||||||
| Diluted | 24,878 | 25,098 | |||||||||||||||||||||
| Condensed Consolidated Statements of Cash Flows | Six Months Ended | ||||||||||
| (Unaudited) | December 31, | ||||||||||
| (Amounts in Thousands) | 2025 | 2024 | |||||||||
| Net Cash Flow provided by Operating Activities | $ | 14,943 | $ | 74,932 | |||||||
Net Cash Flow used for Investing Activities | (24,368) | (1,214) | |||||||||
Net Cash Flow used for Financing Activities | (2,142) | (97,255) | |||||||||
| Effect of Exchange Rate Change on Cash, Cash Equivalents, and Restricted Cash | 623 | (722) | |||||||||
Net Decrease in Cash, Cash Equivalents, and Restricted Cash | (10,944) | (24,259) | |||||||||
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 89,467 | 78,779 | |||||||||
| Cash, Cash Equivalents, and Restricted Cash at End of Period | $ | 78,523 | $ | 54,520 | |||||||
| (Unaudited) | |||||||||||
| Condensed Consolidated Balance Sheets | December 31, 2025 | June 30, 2025 | |||||||||
| (Amounts in Thousands) | |||||||||||
| ASSETS | |||||||||||
| Cash and cash equivalents | $ | 77,853 | $ | 88,781 | |||||||
| Receivables, net | 213,994 | 222,623 | |||||||||
| Contract assets | 79,521 | 71,812 | |||||||||
| Inventories | 281,699 | 273,500 | |||||||||
| Prepaid expenses and other current assets | 32,214 | 36,027 | |||||||||
| Assets held for sale | 6,610 | 6,861 | |||||||||
| Property and Equipment, net | 276,433 | 264,804 | |||||||||
| Goodwill | 6,191 | 6,191 | |||||||||
| Other Intangible Assets, net | 2,182 | 2,427 | |||||||||
Other Assets, net | 106,774 | 104,286 | |||||||||
| Total Assets | $ | 1,083,471 | $ | 1,077,312 | |||||||
LIABILITIES AND SHARE OWNERS’ EQUITY | |||||||||||
| Current portion of long-term debt | $ | 24,112 | $ | 17,400 | |||||||
| Accounts payable | 218,830 | 218,805 | |||||||||
| Advances from customers | 28,439 | 35,867 | |||||||||
| Accrued expenses | 41,995 | 46,489 | |||||||||
| Long-term debt, less current portion | 129,700 | 129,650 | |||||||||
| Other long-term liabilities | 61,233 | 59,217 | |||||||||
| Share Owners’ Equity | 579,162 | 569,884 | |||||||||
| Total Liabilities and Share Owners’ Equity | $ | 1,083,471 | $ | 1,077,312 | |||||||
| Other Financial Metrics | |||||||||||||||||
| (Unaudited) | |||||||||||||||||
| (Amounts in Millions, except CCD) | |||||||||||||||||
| At or For the | |||||||||||||||||
| Three Months Ended | |||||||||||||||||
| December 31, | September 30, | December 31, | |||||||||||||||
| 2025 | 2025 | 2024 | |||||||||||||||
| Depreciation and Amortization | $ | 9.3 | $ | 9.1 | $ | 9.1 | |||||||||||
Cash Conversion Days (CCD) (1) | 91 | 83 | 107 | ||||||||||||||
Open Orders (2) | $ | 557 | $ | 593 | $ | 564 | |||||||||||
Select Financial Results of Automation, Test and Measurement | |||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||
(Amounts in Millions) | |||||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| December 31, | December 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net Sales | $ | — | $ | — | $ | — | $ | 2.1 | |||||||||||||||
Operating Income (Loss) (1) | $ | (0.4) | $ | — | $ | (0.4) | $ | 0.8 | |||||||||||||||
| Reconciliation of Non-GAAP Financial Measures | |||||||||||||||||||||||
| (Unaudited, Amounts in Thousands, except Per Share Data) | |||||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| December 31, | December 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net Sales Growth (vs. same period in prior year) | (5) | % | (15) | % | (3) | % | (15) | % | |||||||||||||||
| Foreign Currency Exchange Impact | 2 | % | — | % | 2 | % | — | % | |||||||||||||||
| Constant Currency Growth | (7) | % | (15) | % | (5) | % | (15) | % | |||||||||||||||
| Selling and Administrative Expenses, as reported | $ | 14,862 | $ | 10,526 | $ | 27,952 | $ | 23,953 | |||||||||||||||
| Stock Compensation Expense | (2,217) | (501) | (3,780) | (2,573) | |||||||||||||||||||
| SERP | (85) | 69 | (310) | (276) | |||||||||||||||||||
| Adjusted Selling and Administrative Expenses | $ | 12,560 | $ | 10,094 | $ | 23,862 | $ | 21,104 | |||||||||||||||
Operating Income, as reported | $ | 10,767 | $ | 8,230 | $ | 25,221 | $ | 17,345 | |||||||||||||||
| Stock Compensation Expense | 2,217 | 501 | 3,780 | 2,573 | |||||||||||||||||||
| SERP | 85 | (69) | 310 | 276 | |||||||||||||||||||
| Restructuring Expense | 1,817 | 4,671 | 3,233 | 6,993 | |||||||||||||||||||
| Asset Impairment (Gain on Disposal) | 422 | — | 298 | (1,264) | |||||||||||||||||||
| Adjusted Operating Income | $ | 15,308 | $ | 13,333 | $ | 32,842 | $ | 25,923 | |||||||||||||||
Net Income, as reported | $ | 3,637 | $ | 3,432 | $ | 13,723 | $ | 6,586 | |||||||||||||||
| Stock Compensation Expense, After-Tax | 1,681 | 380 | 2,866 | 1,951 | |||||||||||||||||||
| Restructuring Expense, After-Tax | 1,287 | 3,542 | 2,360 | 5,303 | |||||||||||||||||||
| Asset Impairment (Gain on Disposal), After-Tax | 320 | — | 226 | (959) | |||||||||||||||||||
| Adjusted Net Income | $ | 6,925 | $ | 7,354 | $ | 19,175 | $ | 12,881 | |||||||||||||||
| Diluted Earnings per Share, as reported | $ | 0.15 | $ | 0.14 | $ | 0.55 | $ | 0.26 | |||||||||||||||
| Stock Compensation Expense | 0.07 | 0.01 | 0.12 | 0.07 | |||||||||||||||||||
| Restructuring Expense | 0.05 | 0.14 | 0.09 | 0.21 | |||||||||||||||||||
| Asset Impairment (Gain on Disposal) | 0.01 | — | 0.01 | (0.03) | |||||||||||||||||||
| Adjusted Diluted Earnings per Share | $ | 0.28 | $ | 0.29 | $ | 0.77 | $ | 0.51 | |||||||||||||||
| Twelve Months Ended | |||||||||||||||||||||||
| December 31, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
Operating Income, as reported | $ | 53,411 | $ | 30,522 | |||||||||||||||||||
| Goodwill Impairment | — | 5,820 | |||||||||||||||||||||
| SERP | 648 | 649 | |||||||||||||||||||||
| Restructuring Expense | 7,230 | 9,379 | |||||||||||||||||||||
| Asset Impairment (Gain on Disposal) | (829) | 15,776 | |||||||||||||||||||||
| Legal Settlements (Recovery) | — | (892) | |||||||||||||||||||||
| Stock Compensation Expense | 7,726 | 6,096 | |||||||||||||||||||||
Adjusted Operating Income | $ | 68,186 | $ | 67,350 | |||||||||||||||||||
| Tax Effect | 23,836 | 17,019 | |||||||||||||||||||||
| After-tax Adjusted Operating Income | $ | 44,350 | $ | 50,331 | |||||||||||||||||||
Average Invested Capital (1) | $ | 657,074 | $ | 756,966 | |||||||||||||||||||
| ROIC | 6.7 | % | 6.6 | % | |||||||||||||||||||